Please assess the completion status of the following clinical trial:

Trial Title: Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of metastatic (stage IV) renal cell carcinoma (RCC) predominately clear cell type~* Prior nephrectomy~* Available HLA-matched (8/8, 7/8) unrelated donor~* At least one prior immunotherapy; or immunotherapy + chemotherapy; or targeted therapy, for metastatic RCC.~* Adequate organ function~Exclusion Criteria:~* Prior allogeneic stem cell transplantation~* RCC with histology other than clear cell type~* History or presence of brain metastasis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- MUD treatment (Type: EXPERIMENTAL): NST using MUD for metastatic renal cell carcinoma

Based on this trial design, predict the completion outcome and termination type (if applicable).